Deutsch
English
Español
Français
Nederlands
Português
Norway's Crown Princess Mette-Marit, 52, has undergone a successful lung transplant at Oslo University Hospital, the Norwegian royal court announced on Wednesday. The procedure was necessary due to pulmonary fibrosis, a chronic lung disease she has battled since 2018. The surgery comes after her health deteriorated rapidly, with doctors warning that without a transplant, her life expectancy was approximately one year.
What is Pulmonary Fibrosis?
Pulmonary fibrosis is a progressive lung disease characterized by scarring of lung tissue, which reduces the lungs' ability to absorb oxygen. Symptoms include shortness of breath, a persistent dry cough, fatigue, and unexplained weight loss. The condition has no known cure, and treatment focuses on managing symptoms and, in advanced cases, lung transplantation. Mette-Marit was diagnosed with the condition in 2018 and had been receiving treatment while continuing her royal duties when possible.
Details of the Transplant
Professor Are Holm of Oslo University Hospital confirmed in a statement released by the royal court that the transplant was successful. "The crown princess is recovering well under medical supervision and will remain in hospital for several weeks, as is standard for all transplant recipients," Holm said. The hospital placed Mette-Marit on the transplant waiting list earlier this month after her condition became life-threatening.
A Surge in Organ Donors
News of Mette-Marit's illness has had an unexpected positive side effect: a dramatic increase in organ donor registrations across Norway. According to the Organ Donation Foundation, the daily average of 70 registrations surged to 2,178 on the day after her placement on the waiting list was announced — a 31-fold increase. Aleksander Sekowski, head of information at the foundation, called it "attention that will save many lives." The surge highlights how high-profile health disclosures can drive public action, a phenomenon also seen in other countries when public figures share their medical struggles. The impact of royal health disclosures on public behavior has been studied by social scientists as a powerful tool for raising awareness.
Health Challenges and Royal Duties
Mette-Marit has been open about her health struggles over the years. In 2018, she stepped back from some official engagements to focus on her treatment. Her condition forced her to limit travel and public appearances, particularly during the COVID-19 pandemic, when she was considered high-risk. Despite these challenges, she continued to support her husband, Crown Prince Haakon, in his duties as heir to the throne.
The crown princess has also faced personal difficulties beyond her health. Her eldest son, Marius Borg Høiby (29), from a previous relationship, was recently sentenced to four years in prison for rape and domestic violence. The case has been a source of media scrutiny and personal pain for the royal family. Additionally, Mette-Marit faced criticism in 2024 for her past association with convicted sex offender Jeffrey Epstein, for which she publicly apologized. These events have contributed to a decline in public support for the Norwegian monarchy, which dropped to 60% in February before recovering slightly to 64% in May, according to recent polls.
Recovery and Outlook
Lung transplant recovery is a lengthy process. Patients typically remain hospitalized for several weeks to monitor for complications such as organ rejection or infection. After discharge, a strict regimen of immunosuppressive medications and regular follow-up appointments is required. The five-year survival rate for lung transplant recipients is approximately 50-60%, though outcomes have improved with advances in surgical techniques and post-operative care. The royal court has asked for privacy during Mette-Marit's recovery, stating that updates will be provided as appropriate.
Norway's health minister expressed relief at the successful surgery, stating, "The crown princess's courage in sharing her journey has inspired countless Norwegians. We wish her a full and speedy recovery." The royal family has also thanked the anonymous donor and their family, emphasizing the gift of life that organ donation represents.
The growth of Norway's organ donation program has been a topic of national discussion since the princess's diagnosis. The government is considering new initiatives to further boost registration rates, including a presumed consent model similar to those in other European countries.
FAQ
What is pulmonary fibrosis?
Pulmonary fibrosis is a chronic lung disease that causes scarring of lung tissue, making it difficult for the lungs to absorb oxygen. It can be caused by environmental factors, certain medications, or autoimmune conditions, but in many cases, the cause is unknown.
How long does recovery from a lung transplant take?
Initial hospitalization typically lasts 2-4 weeks. Full recovery can take 6-12 months, with ongoing monitoring and medication for life to prevent organ rejection.
Did the crown princess's illness really increase organ donor registrations?
Yes. After news broke that Mette-Marit was on the transplant waiting list, daily registrations surged from an average of 70 to over 2,000 in a single day — a 31-fold increase, according to the Organ Donation Foundation.
Will Mette-Marit be able to resume royal duties?
It is expected that she will gradually return to a limited schedule after recovery, but her doctors will advise on the extent of activities she can safely undertake. The royal court has not provided a timeline.
What is the success rate of lung transplants?
The five-year survival rate for lung transplant recipients is approximately 50-60%, though survival rates vary based on age, overall health, and adherence to post-transplant care.
Follow Discussion